Search research articles
Contact Us
Filters
Showing results (101-110 of 194) with videos related to
Page
of 20
Sort By:
Gynecologic Oncology
|
August 11, 2024
Increased TP53 somatic evolution in peritoneal washes of individuals with BRCA1 germline mutations
Xin Ray Tee, Emma Hazard, Elena Latorre-Esteves, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 12, 2022
Phase 1b Clinical Trial with Alpelisib plus Olaparib for Patients with Advanced Triple-Negative Breast Cancer
Felipe Batalini, Niya Xiong, Nabihah Tayob, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
July 31, 2021
PolyG-DS: An ultrasensitive polyguanine tract-profiling method to detect clonal expansions and trace cell lineage
Yuezheng Zhang, Brendan F Kohrn, Ming Yang, et al.
BMC Cancer
|
July 4, 2019
MAGENTA (Making Genetic testing accessible): a prospective randomized controlled trial comparing online genetic education and telephone genetic counseling for hereditary cancer genetic testing
Nadine Rayes, Deborah J Bowen, Tara Coffin, et al.
JCO Precision Oncology
|
May 17, 2023
Diagnosis of Ovarian Carcinoma Homologous Recombination DNA Repair Deficiency From Targeted Gene Capture Oncology Assays
Niklas Krumm, Nithisha S Khasnavis, Marc Radke, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
April 12, 2023
TUBectomy with delayed oophorectomy as an alternative to risk-reducing salpingo-oophorectomy in high-risk women to assess the safety of prevention: the TUBA-WISP II study protocol
Miranda P Steenbeek, Majke H D van Bommel, Joanna intHout, et al.
Nucleic Acids Research
|
September 16, 2011
An integrative genomic approach identifies p73 and p63 as activators of miR-200 microRNA family transcription
Emily C Knouf, Kavita Garg, Jason D Arroyo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 22, 2022
CA-125 KELIM as a Potential Complementary Tool for Predicting Veliparib Benefit: An Exploratory Analysis From the VELIA/GOG-3005 Study
Benoit You, Vasudha Sehgal, Balakrishna Hosmane, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 25, 2025
Veliparib concomitant with first-line chemotherapy and as maintenance therapy in ovarian cancer: Final overall survival and disease-related symptoms results
Robert L Coleman, Gini F Fleming, Mark F Brady, et al.
JAMA Network Open
|
March 7, 2025
Strategies to Assess Risk for Hereditary Cancer in Primary Care Clinics: A Cluster Randomized Clinical Trial
Elizabeth M Swisher, Heather M Harris, Sarah Knerr, et al.
Page
of 20
Search research articles
Search
Showing results (101-110 of 194) with videos related to
Sort By:
Page
of 20
Gynecologic Oncology
|
August 11, 2024
Increased TP53 somatic evolution in peritoneal washes of individuals with BRCA1 germline mutations
Xin Ray Tee, Emma Hazard, Elena Latorre-Esteves, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 12, 2022
Phase 1b Clinical Trial with Alpelisib plus Olaparib for Patients with Advanced Triple-Negative Breast Cancer
Felipe Batalini, Niya Xiong, Nabihah Tayob, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
July 31, 2021
PolyG-DS: An ultrasensitive polyguanine tract-profiling method to detect clonal expansions and trace cell lineage
Yuezheng Zhang, Brendan F Kohrn, Ming Yang, et al.
BMC Cancer
|
July 4, 2019
MAGENTA (Making Genetic testing accessible): a prospective randomized controlled trial comparing online genetic education and telephone genetic counseling for hereditary cancer genetic testing
Nadine Rayes, Deborah J Bowen, Tara Coffin, et al.
JCO Precision Oncology
|
May 17, 2023
Diagnosis of Ovarian Carcinoma Homologous Recombination DNA Repair Deficiency From Targeted Gene Capture Oncology Assays
Niklas Krumm, Nithisha S Khasnavis, Marc Radke, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
April 12, 2023
TUBectomy with delayed oophorectomy as an alternative to risk-reducing salpingo-oophorectomy in high-risk women to assess the safety of prevention: the TUBA-WISP II study protocol
Miranda P Steenbeek, Majke H D van Bommel, Joanna intHout, et al.
Nucleic Acids Research
|
September 16, 2011
An integrative genomic approach identifies p73 and p63 as activators of miR-200 microRNA family transcription
Emily C Knouf, Kavita Garg, Jason D Arroyo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 22, 2022
CA-125 KELIM as a Potential Complementary Tool for Predicting Veliparib Benefit: An Exploratory Analysis From the VELIA/GOG-3005 Study
Benoit You, Vasudha Sehgal, Balakrishna Hosmane, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 25, 2025
Veliparib concomitant with first-line chemotherapy and as maintenance therapy in ovarian cancer: Final overall survival and disease-related symptoms results
Robert L Coleman, Gini F Fleming, Mark F Brady, et al.
JAMA Network Open
|
March 7, 2025
Strategies to Assess Risk for Hereditary Cancer in Primary Care Clinics: A Cluster Randomized Clinical Trial
Elizabeth M Swisher, Heather M Harris, Sarah Knerr, et al.
Page
of 20